Lineage Cell Therapeutics, Inc. Deferred Income Tax Expense (Benefit)
Lineage Cell Therapeutics, Inc. (LCTX) reported Deferred Income Tax Expense (Benefit) of $0 for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:DeferredIncomeTaxExpenseBenefit · last filed 2026-08-06
- Lineage Cell Therapeutics, Inc. deferred income tax expense (benefit) for the quarter ending 2026-06-30 was $0.00.
- Lineage Cell Therapeutics, Inc. deferred income tax expense (benefit) for the quarter ending 2026-03-31 was $0.00.
- Lineage Cell Therapeutics, Inc. deferred income tax expense (benefit) for the quarter ending 2025-12-31 was -$5.28M.
- Lineage Cell Therapeutics, Inc. deferred income tax expense (benefit) for the quarter ending 2025-09-30 was $0.00.
- Lineage Cell Therapeutics, Inc. deferred income tax expense (benefit) for fiscal 2025 was -$5.28M.
- Lineage Cell Therapeutics, Inc. deferred income tax expense (benefit) for fiscal 2024 was $0.00.
- Lineage Cell Therapeutics, Inc. deferred income tax expense (benefit) for fiscal 2023 was -$1.80M.
- Lineage Cell Therapeutics, Inc. deferred income tax expense (benefit) for fiscal 2022 was $0.00.
| Period end | Deferred Income Tax Expense (Benefit) 3 month | Deferred Income Tax Expense (Benefit) 3 month as first filed | Deferred Income Tax Expense (Benefit) 6 month | Deferred Income Tax Expense (Benefit) 6 month as first filed | Deferred Income Tax Expense (Benefit) 9 month | Deferred Income Tax Expense (Benefit) 9 month as first filed | Deferred Income Tax Expense (Benefit) 12 month | Deferred Income Tax Expense (Benefit) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-06 | $0.00 10-Q · filed 2026-08-06 | -$5.28M derived: sum of 3 quarters · filed 2026-08-06 | -$5.28M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | $0.00 10-Q · filed 2026-05-12 | -$5.28M derived: sum of 2 quarters · filed 2026-05-12 | -$5.28M derived: sum of 3 quarters · filed 2026-05-12 | -$5.28M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-12-31 | -$5.28M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | -$5.28M derived: sum of 2 quarters · filed 2026-03-05 | -$5.28M derived: sum of 3 quarters · filed 2026-08-06 | -$5.28M 10-K · filed 2026-03-05 | ||||
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $0.00 derived: sum of 2 quarters · filed 2026-08-06 | $0.00 10-Q · filed 2025-11-06 | $0.00 derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-30 | $0.00 10-Q · filed 2026-08-06 | $0.00 10-Q · filed 2026-08-06 | $0.00 derived: sum of 3 quarters · filed 2026-08-06 | $0.00 derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-03-31 | $0.00 10-Q · filed 2026-05-12 | $0.00 derived: sum of 2 quarters · filed 2026-05-12 | $0.00 derived: sum of 3 quarters · filed 2026-05-12 | $0.00 derived: sum of 4 quarters · filed 2026-05-12 | ||||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $0.00 derived: sum of 2 quarters · filed 2026-03-05 | $0.00 derived: sum of 3 quarters · filed 2026-03-05 | $0.00 10-K · filed 2026-03-05 | ||||
| 2024-09-30 | $0.00 10-Q · filed 2024-11-14 | $0.00 derived: sum of 2 quarters · filed 2025-08-12 | $0.00 10-Q · filed 2025-11-06 | $0.00 derived: sum of 4 quarters · filed 2025-08-12 | ||||
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $0.00 10-Q · filed 2025-08-12 | $0.00 derived: sum of 3 quarters · filed 2025-08-12 | $0.00 derived: sum of 4 quarters · filed 2025-08-12 | ||||
| 2024-03-31 | $0.00 10-Q · filed 2025-05-13 | $0.00 derived: sum of 2 quarters · filed 2025-05-13 | $0.00 derived: sum of 3 quarters · filed 2025-05-13 | -$3.00K derived: sum of 4 quarters · filed 2025-05-13 | ||||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-10 | $0.00 derived: sum of 2 quarters · filed 2025-03-10 | -$3.00K derived: sum of 3 quarters · filed 2025-03-10 | -$1.80M 10-K · filed 2025-03-10 | ||||
| 2023-09-30 | $0.00 10-Q · filed 2024-11-14 | -$3.00K derived: sum of 2 quarters · filed 2024-11-14 | -$1.80M 10-Q · filed 2024-11-14 | |||||
| 2023-06-30 | -$3.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$1.80M 10-Q · filed 2024-08-08 | ||||||
| 2023-03-31 | -$1.80M 10-Q · filed 2024-11-14 | -$1.80M 10-Q · filed 2023-05-11 | ||||||
| 2022-12-31 | $0.00 10-K · filed 2024-03-07 | |||||||
| 2021-09-30 | -$1.01M 10-Q · filed 2021-11-10 | -$1.18M derived: sum of 2 quarters · filed 2022-08-11 | -$1.18M 10-Q · filed 2022-11-10 | |||||
| 2021-06-30 | -$169.00K 10-Q · filed 2022-08-11 | -$169.00K 10-Q · filed 2022-08-11 | ||||||
| 2020-12-31 | -$1.06M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | -$1.24M derived: sum of 2 quarters · filed 2022-03-10 | -$1.24M 10-K · filed 2022-03-10 | |||||
| 2020-09-30 | -$178.00K 10-Q · filed 2021-11-10 | -$178.00K 10-Q · filed 2021-11-10 | ||||||
| 2019-09-30 | -$991.00K 10-Q · filed 2020-11-04 | -$2.24M derived: sum of 2 quarters · filed 2020-11-04 | -$6.62M 10-Q · filed 2020-11-04 | |||||
| 2019-06-30 | -$1.25M 10-Q · filed 2020-08-06 | -$5.63M 10-Q · filed 2020-08-06 | ||||||
| 2019-03-31 | -$4.38M 10-Q · filed 2019-05-09 | |||||||
| 2017-09-30 | $4.77M 10-Q · filed 2018-11-08 | $895.00K derived: sum of 2 quarters · filed 2018-11-08 | $4.77M 10-Q · filed 2018-11-08 | $4.79M derived: sum of 4 quarters · filed 2018-11-08 | ||||
| 2017-06-30 | -$3.88M 10-Q · filed 2018-08-02 | $0.00 10-Q · filed 2017-08-09 | $23.00K derived: sum of 3 quarters · filed 2018-08-02 | $23.00K derived: sum of 4 quarters · filed 2018-08-02 | ||||
| 2017-03-31 | $3.90M 10-Q · filed 2018-08-02 | $3.88M 10-Q · filed 2017-05-10 | $3.90M derived: sum of 2 quarters · filed 2018-08-02 | $3.90M derived: sum of 3 quarters · filed 2018-08-02 | $3.90M derived: sum of 4 quarters · filed 2018-08-02 | |||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | $0.00 derived: sum of 2 quarters · filed 2017-11-09 | $0.00 derived: sum of 3 quarters · filed 2017-11-09 | $0.00 10-K · filed 2017-03-16 | ||||
| 2016-09-30 | $0.00 10-Q · filed 2017-11-09 | $0.00 derived: sum of 2 quarters · filed 2017-11-09 | $0.00 10-Q · filed 2017-11-09 | -$1.12M derived: sum of 4 quarters · filed 2018-03-15 | ||||
| 2016-06-30 | $0.00 10-Q · filed 2017-08-09 | $0.00 10-Q · filed 2017-08-09 | -$1.12M derived: sum of 3 quarters · filed 2018-03-15 | -$2.07M derived: sum of 4 quarters · filed 2018-03-15 | ||||
| 2016-03-31 | $0.00 10-Q · filed 2017-05-10 | -$1.12M derived: sum of 2 quarters · filed 2018-03-15 | -$2.07M derived: sum of 3 quarters · filed 2018-03-15 | -$3.34M derived: sum of 4 quarters · filed 2018-03-15 | ||||
| 2015-12-31 | -$1.12M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | -$2.07M derived: sum of 2 quarters · filed 2018-03-15 | -$3.34M derived: sum of 3 quarters · filed 2018-03-15 | -$4.52M 10-K · filed 2018-03-15 | ||||
| 2015-09-30 | -$948.00K 10-Q · filed 2016-11-04 | -$2.22M derived: sum of 2 quarters · filed 2016-11-04 | -$3.40M 10-Q · filed 2016-11-04 | -$5.60M derived: sum of 4 quarters · filed 2017-03-16 | ||||
| 2015-06-30 | -$1.27M 10-Q · filed 2016-08-09 | -$2.45M 10-Q · filed 2016-08-09 | -$4.65M derived: sum of 3 quarters · filed 2017-03-16 | -$6.96M derived: sum of 4 quarters · filed 2017-03-16 | ||||
| 2015-03-31 | -$1.18M 10-Q · filed 2016-05-10 | -$1.18M 10-Q · filed 2015-05-08 | -$3.38M derived: sum of 2 quarters · filed 2017-03-16 | -$5.69M derived: sum of 3 quarters · filed 2017-03-16 | -$7.20M derived: sum of 4 quarters · filed 2017-03-16 | |||
| 2014-12-31 | -$2.20M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | -$4.51M derived: sum of 2 quarters · filed 2017-03-16 | -$6.03M derived: sum of 3 quarters · filed 2017-03-16 | -$7.38M 10-K · filed 2017-03-16 | -$7.38M 10-K · filed 2015-03-11 | |||
| 2014-09-30 | -$2.31M 10-Q · filed 2015-11-09 | -$3.83M derived: sum of 2 quarters · filed 2015-11-09 | -$5.17M 10-Q · filed 2015-11-09 | -$5.17M 10-Q · filed 2014-11-07 | -$8.46M derived: sum of 4 quarters · filed 2016-03-15 | |||
| 2014-06-30 | -$1.51M 10-Q · filed 2015-08-10 | -$2.86M 10-Q · filed 2015-08-10 | -$2.86M 10-Q · filed 2014-08-11 | -$6.14M derived: sum of 3 quarters · filed 2016-03-15 | -$6.14M derived: sum of 4 quarters · filed 2016-03-15 | |||
| 2014-03-31 | -$1.35M 10-Q · filed 2015-05-08 | -$4.63M derived: sum of 2 quarters · filed 2016-03-15 | -$4.63M derived: sum of 3 quarters · filed 2016-03-15 | -$4.63M derived: sum of 4 quarters · filed 2016-03-15 | ||||
| 2013-12-31 | -$3.28M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15 | -$3.28M derived: sum of 2 quarters · filed 2016-03-15 | -$3.28M derived: sum of 3 quarters · filed 2016-03-15 | -$3.28M 10-K · filed 2016-03-15 | -$3.28M 10-K · filed 2014-03-17 | |||
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07 | $0.00 derived: sum of 2 quarters · filed 2014-11-07 | $0.00 10-Q · filed 2014-11-07 | |||||
| 2013-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-11 | $0.00 10-Q · filed 2014-08-11 | ||||||
| 2013-03-31 | $0.00 10-Q · filed 2014-05-12 | |||||||
| 2012-12-31 | $0.00 10-K · filed 2015-03-11 | |||||||
| 2011-12-31 | $0.00 10-K · filed 2014-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Invivyd, Inc. (IVVD) | United States | $0.270B | -2.42 |
| PALISADE BIO, INC. (PALI) | United States | $0.275B | -11.41 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Lexeo Therapeutics, Inc. (LXEO) | United States | $0.278B | -4.19 |
| FATE THERAPEUTICS INC (FATE) | United States | $0.280B | -2.51 |